Cubist Pharmaceuticals Inc

Most Recent

  • uploads///ASH
    Materials

    Must-know: Why Maverick adds new position in Ashland

    Ashland has seen pressure from activist investor JANA Partners, which acquired a stake in the chemical maker in April, 2013, to boost shareholder value.

    By Samantha Nielson
  • uploads///CBST
    Fund Managers

    Elliott Management starts new position in Cubist Pharmaceuticals

    Cubist Pharmaceuticals has grown its pipeline via acquisitions. In 2013, it acquired Trius Therapeutics, obtaining rights to tedizolid phosphate.

    By Adam Rogers
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.